Use of capecitabine in management of early colon cancer.
about
Pharmacogenetic variants in the DPYD, TYMS, CDA and MTHFR genes are clinically significant predictors of fluoropyrimidine toxicitySeven-day capecitabine plus docetaxel and oxaliplatin regimen for the treatment of advanced gastric cancer: A phase-I clinical trial.Emerging new therapeutic applications of capecitabine as a first-line chemotherapeutic agent in the management of advanced carcinomas other than colorectal carcinoma.Ileitis secondary to oral capecitabine treatment?
P2860
Use of capecitabine in management of early colon cancer.
description
2011 nî lūn-bûn
@nan
2011 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Use of capecitabine in management of early colon cancer.
@ast
Use of capecitabine in management of early colon cancer.
@en
type
label
Use of capecitabine in management of early colon cancer.
@ast
Use of capecitabine in management of early colon cancer.
@en
prefLabel
Use of capecitabine in management of early colon cancer.
@ast
Use of capecitabine in management of early colon cancer.
@en
P2860
P356
P1476
Use of capecitabine in management of early colon cancer.
@en
P2093
P2860
P304
P356
10.2147/CMR.S12704
P407
P577
2011-08-19T00:00:00Z